{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:01:24Z","timestamp":1783008084716,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["2019R1A2C2002393 (C.S.L.)"],"award-info":[{"award-number":["2019R1A2C2002393 (C.S.L.)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00417-021-05180-6","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T18:04:28Z","timestamp":1619546668000},"page":"2391-2400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pachydrusen, choroidal vascular hyperpermeability, and punctate hyperfluorescent spots"],"prefix":"10.1007","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8359-9618","authenticated-orcid":false,"given":"Hyun Goo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-6959","authenticated-orcid":false,"given":"Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8101-0830","authenticated-orcid":false,"given":"Suk Ho","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-7993","authenticated-orcid":false,"given":"Sung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5932-8516","authenticated-orcid":false,"given":"Hyoung Jun","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-9470","authenticated-orcid":false,"given":"Christopher Seungkyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"5180_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53:107\u2013139","journal-title":"Prog Retin Eye Res"},{"key":"5180_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125:708\u2013724","journal-title":"Ophthalmology"},{"key":"5180_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K, Wong TY, Chen L-J, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK, for the EIIsg (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135:1206\u20131213","journal-title":"JAMA Ophthalmol"},{"key":"5180_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","volume":"99","author":"CS Tan","year":"2015","unstructured":"Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH, Group ES (2015) EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 99:624\u2013628","journal-title":"Br J Ophthalmol"},{"key":"5180_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","volume":"36","author":"KK Dansingani","year":"2016","unstructured":"Dansingani KK, Balaratnasingam C, Naysan J, Freund KB (2016) En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 36:499\u2013516","journal-title":"Retina"},{"key":"5180_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/IAE.0000000000002019","volume":"39","author":"J Lee","year":"2019","unstructured":"Lee J, Byeon SH (2019) Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study. Retina 39:670\u2013678","journal-title":"Retina"},{"key":"5180_CR7","doi-asserted-by":"crossref","unstructured":"Chang Y, Cheng C (2019) Difference between pachychoroid and nonpachychoroid polypoidal cohroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina\u00a040(7):1403\u20131411","DOI":"10.1097\/IAE.0000000000002583"},{"key":"5180_CR8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","volume":"33","author":"DJ Warrow","year":"2013","unstructured":"Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33:1659\u20131672","journal-title":"Retina"},{"key":"5180_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000774","volume":"36","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M, Freund KB (2016) Polypoidal choroidal vasculopathy: a distinct disease or manifestation of many? Retina 36:1\u20138","journal-title":"Retina"},{"key":"5180_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","volume":"35","author":"CE Pang","year":"2015","unstructured":"Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina 35:1\u20139","journal-title":"Retina"},{"key":"5180_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3928\/23258160-20150422-04","volume":"46","author":"H Kim","year":"2015","unstructured":"Kim H, Lee JH, Kwon KY, Byeon SH, Lee SC, Lee CS (2015) Punctate hyperfluorescent spots associated with polypoidal choroidal vasculopathy on indocyanine green angiography. Ophthalmic Surg Lasers Imaging Retina 46:423\u2013427","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5180_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","volume":"16","author":"RF Spaide","year":"1996","unstructured":"Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203\u2013213","journal-title":"Retina"},{"issue":"305\u2013313","key":"5180_CR13","first-page":"e301","volume":"155","author":"H Koizumi","year":"2013","unstructured":"Koizumi H, Yamagishi T, Yamazaki T, Kinoshita S (2013) Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol 155(305\u2013313):e301","journal-title":"Am J Ophthalmol"},{"issue":"594\u2013603","key":"5180_CR14","first-page":"e591","volume":"151","author":"I Maruko","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T (2011) Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 151(594\u2013603):e591","journal-title":"Am J Ophthalmol"},{"key":"5180_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ajo.2006.05.051","volume":"142","author":"M Sasahara","year":"2006","unstructured":"Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M, Yoshimura N (2006) Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 142:601\u2013607","journal-title":"Am J Ophthalmol"},{"key":"5180_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","volume":"118","author":"SE Chung","year":"2011","unstructured":"Chung SE, Kang SW, Lee JH, Kim YT (2011) Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118:840\u2013845","journal-title":"Ophthalmology"},{"key":"5180_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/IAE.0b013e3181c72068","volume":"30","author":"A Tsujikawa","year":"2010","unstructured":"Tsujikawa A, Ojima Y, Yamashiro K, Ooto S, Tamura H, Nakagawa S, Yoshimura N (2010) Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina 30:801\u2013809","journal-title":"Retina"},{"key":"5180_CR18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/IAE.0000000000001689","volume":"38","author":"RF Spaide","year":"2018","unstructured":"Spaide RF (2018) Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina 38:708\u2013716","journal-title":"Retina"},{"key":"5180_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB (2019) Pachychoroid disease. Eye (Lond) 33:14\u201333","journal-title":"Eye (Lond)"},{"key":"5180_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/ceo.13438","volume":"47","author":"J Baek","year":"2019","unstructured":"Baek J, Lee JH, Chung BJ, Lee K, Lee WK (2019) Choroidal morphology under pachydrusen. Clin Exp Ophthalmol 47:498\u2013504","journal-title":"Clin Exp Ophthalmol"},{"issue":"1155\u20131163","key":"5180_CR21","first-page":"e1151","volume":"158","author":"SJ Park","year":"2014","unstructured":"Park SJ, Kim BH, Park KH, Woo SJ (2014) Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy. Am J Ophthalmol 158(1155\u20131163):e1151","journal-title":"Am J Ophthalmol"},{"key":"5180_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjo.2009.178400","volume":"95","author":"B Guigui","year":"2011","unstructured":"Guigui B, Leveziel N, Martinet V, Massamba N, Sterkers M, Coscas G, Souied EH (2011) Angiography features of early onset drusen. Br J Ophthalmol 95:238\u2013244","journal-title":"Br J Ophthalmol"},{"key":"5180_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.preteyeres.2013.08.003","volume":"37","author":"CJ Boon","year":"2013","unstructured":"Boon CJ, van de Ven JP, Hoyng CB, den Hollander AI, Klevering BJ (2013) Cuticular drusen: stars in the sky. Prog Retin Eye Res 37:90\u2013113","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"5180_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajo.2011.08.012","volume":"153","author":"MY Lee","year":"2012","unstructured":"Lee MY, Yoon J, Ham DI (2012) Clinical characteristics of reticular pseudodrusen in Korean patients. Am J Ophthalmol 153(3):530\u2013535","journal-title":"Am J Ophthalmol"},{"key":"5180_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/bjo.83.3.358","volume":"83","author":"SH Sarks","year":"1999","unstructured":"Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP (1999) Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol 83:358\u2013368","journal-title":"Br J Ophthalmol"},{"key":"5180_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40662-018-0118-x","volume":"5","author":"M Arya","year":"2018","unstructured":"Arya M, Sabrosa AS, Duker JS, Waheed NK (2018) Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review. Eye Vis (Lond) 5:22","journal-title":"Eye Vis (Lond)"},{"key":"5180_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1795206:1-9","author":"HG Kang","year":"2020","unstructured":"Kang HG, Kim TY, Kim M, Byeon SH, Kim SS, Koh HJ, Lee SC, Lee CS (2020) Expanding the clinical spectrum of multiple evanescent white dot syndrome with overlapping multifocal choroiditis. Ocul Immunol Inflamm. https:\/\/doi.org\/10.1080\/09273948.2020.1795206:1-9","journal-title":"Ocul Immunol Inflamm"},{"key":"5180_CR28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/ceo.13198","volume":"46","author":"HG Kang","year":"2018","unstructured":"Kang HG, Kang H, Byeon SH, Kim SS, Koh HJ, Lee SC, Kim M (2018) Long-term visual outcomes for treatment of submacularhaemorrhage secondary to polypoidal choroidal vasculopathy. Clin Exp Ophthalmol 46:916\u2013925","journal-title":"Clin Exp Ophthalmol"},{"key":"5180_CR29","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/IAE.0000000000001758","volume":"38","author":"Y Yanagi","year":"2018","unstructured":"Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY, Cheung GCM (2018) Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina 38:1509\u20131517","journal-title":"Retina"},{"issue":"1192\u20131200","key":"5180_CR30","first-page":"e1191","volume":"156","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Kim HS, Jang YS, Han JI, Lew YJ, Lee TG, Kim CG, Kim JW (2013) Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. Am J Ophthalmol 156(1192\u20131200):e1191","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05180-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T03:54:52Z","timestamp":1628567692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05180-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5180"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05180-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"28 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) approval was obtained (Gangnam Severance Hospital IRB No. 3\u20132019-0198).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patient consent was waived after institutional review board (IRB) approval (Gangnam Severance Hospital IRB No. 3\u20132019-0198).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}